Divisional Director, Corporate Partnerships, MRC Technologies (UK)
Dr Rosenkranz is the project leader of the Spinnovator a joint project of Ascenion and
Vesalius Biotech for the creation of spin-offs out of Ascenion partner institutes. She is
responsible for running the Spinnovator and its projects on content and operational level and
involved in its strategic development.
Dr Rosenkranz brings in-depth expertise in scientific research and many years of industry
experience to the team. After completing her PhD at the Max Planck Institute for
Neurobiology, Munich she worked as an investment analyst with a European Venture Capital
Fund before she became an independent consultant and interim manager for young growth
In this function, she supported her clients in strategic and organizational
development, fundraising, HR management and financial planning. Among others, she was
strongly involved in the development and fundraising of the medical device company Hepa
Dr. Rosenkranz holds a MSc / Diploma and PhD in Biochemistry, University
Witten/Herdecke, Germany and a MBA with focus on healthcare and medical devices from
the IBST, Germany.